can tirzepatide cause low blood pressure Cardiovascular effects of Tirzepatide and blood pressure reduction:
Description
FDA approval is expected in 2027 or 2028
ENDO 2025 data (Castaneda) found menopausal women on tirzepatide + MHT lost 18.7% body weight versus 13.7% in non-MHT users by month 15
Researchers warn that these findings should serve as a cautionary tale about the potential long-term health risks of these medications
The Bottom Line GLP-1 medications are powerful tools for weight loss and metabolic health
doi: 10.3389/fphar.2019.00856
On September 25th, Bristol Myers Squibb announced direct-to-patient platforms for Eliquis and Sotyktu
